DVLT news

DataMEDS AI terminated its acquisition LOI with Datavault AI Inc. and related entities due to market conditions. The company preserved its existing agreements and confirmed no outstanding termination fees.

DataMeds AI filed an 8-K announcing a second amended and restated letter of intent for a business combination involving Datavault AI, Scilex, and other entities, but emphasized no binding agreement exists.

The company amended a convertible promissory note to establish a floor price. Instrument acts as a modifying document for the debt entering into effect as of October 15, 2026.

Datavault AI closed its acquisition of NYIAX to integrate institutional-grade exchange technology and blockchain settlement infrastructure into its digital asset and real-world asset tokenization platform.

Datavault AI Inc. has entered into an Agreement and Plan of Merger dated August 19, 2026, involving Datavault AI, a merger sub, and WDT, LLC, to execute a business combination.

DataMEDS AI, Inc. and Datavault AI Inc. executed an amended and restated Letter of Intent to combine platforms; however, they also agreed to the execution of a definitive license agreement for distribution technology.

Datavault AI Inc. named CBIZ CPAs P.C. as its new independent registered public accounting firm. This appointment underscores the company's continued commitment to high standards of financial reporting and corporate governance.

Datavault AI executed a non-binding term sheet for a $2.0 billion dilutive structured financing that would value shares at $1.55-$2.00 per share, with the counterparty agreeing to route all digital asset tokenization projects exclusively through the company's platform. The financing is anchored by a…